Barclays has recently initiated Aspen Aerogels Inc (ASPN) stock to Overweight rating, as announced on August 6, 2024, according to Finviz. Earlier, on March 6, 2024, ROTH MKM had initiated the stock to Buy, setting a price target of $22. The Benchmark Company also raised Buy rating with a price target of $14. Additionally, Canaccord Genuity resumed Buy rating on October 21, 2022, with a target price of $20. The Benchmark Company analysts, in their report published on December 10, 2021, also initiated Buy rating and set a price target of $70 for Aspen Aerogels Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Aspen Aerogels Inc (ASPN) Stock Trading Recap
On Wednesday, Aspen Aerogels Inc (ASPN) stock saw a decline, ending the day at $19.91 which represents a decrease of $-0.48 or -2.35% from the prior close of $20.39. The stock opened at $20.11 and touched a low of $19.49 during the day, reaching a high of $20.57. The volume of shares traded was 2.61 million exceeding the average volume of 2.12 million.
Sponsored
ASPN Stock Performance and Moving Averages
In recent trading, Aspen Aerogels Inc (ASPN) stock price has shown some volatility, fluctuating -21.65% over the last five trades and -27.12% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by 19.65%, and it has plunged by -7.99% in the previous three months. Currently, ASPN is trading at -16.44%, -22.60%, and -7.36% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, ASPN, a Industrials sector stock, is trading -39.94% below its 52-week high but remains 200.76% above its 52-week low. The Average True Range (ATR) (14 days) of 1.94 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
Aspen Aerogels Inc’s Profitability and Valuation Ratios
Aspen Aerogels Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 33.50% and a profit margin of 0.35%, with a gross margin of 19.65%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, Aspen Aerogels Inc’s market capitalization stands at $1.53 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The stock’s price-to-earnings (P/E) ratio is 1567.72, assessing the company’s valuation relative to its earnings. The forward P/E ratio, which uses projected earnings for the next financial year, is 40.63. Additionally, the Price-to-Sales Ratio is 3.71, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 2.96, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.74% of Aspen Aerogels Inc (ASPN)’s shares, while financial institutions hold 92.43%.
Notable insider trades include Young Donald R, President and CEO at Aspen Aerogels Inc (ASPN), who sold 63355 shares on Sep 30 ’24, at $30.03 each, totaling $1.90 million. On Aug 26 ’24, RODRIGUEZ RICARDO C., CFO & Treasurer, sold 32465 shares for $30.14 each, amounting to $0.98 million. Additionally, on May 28 ’24, Young Donald R sold 256944 shares at $29.24 each, generating $7.51 million.
